A Survey of Patient-Relevant Outcomes in Pediatric Craniopharyngioma: Focus on Hypothalamic Obesity

ContextIndividuals treated for pediatric craniopharyngioma, a rare, grade 1 brain tumor, frequently develop hypothalamic obesity, a complication often recalcitrant to intervention. Although hypothalamic obesity is known to adversely impact quality of life, less is known about how caregivers and pati...

Full description

Bibliographic Details
Main Authors: Meghan Craven, Julia H. Crowley, Lucas Chiang, Cassie Kline, Fatema Malbari, Matthew C. Hocking, Shana E. McCormack
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2022.876770/full
_version_ 1811305380605591552
author Meghan Craven
Julia H. Crowley
Lucas Chiang
Cassie Kline
Fatema Malbari
Matthew C. Hocking
Matthew C. Hocking
Shana E. McCormack
author_facet Meghan Craven
Julia H. Crowley
Lucas Chiang
Cassie Kline
Fatema Malbari
Matthew C. Hocking
Matthew C. Hocking
Shana E. McCormack
author_sort Meghan Craven
collection DOAJ
description ContextIndividuals treated for pediatric craniopharyngioma, a rare, grade 1 brain tumor, frequently develop hypothalamic obesity, a complication often recalcitrant to intervention. Although hypothalamic obesity is known to adversely impact quality of life, less is known about how caregivers and patients experience this condition.ObjectiveOur goal was to examine the approaches that families take towards weight management and the impact on social function in individuals with craniopharyngioma and obesity. Individuals with craniopharyngioma without obesity were included as a comparison.Subjects and MethodsAdult caregivers of children <18y with craniopharyngioma completed a web-based survey posted by a patient advocacy organization between February and July 2020. Questions related to the child’s diagnosis, medications, lifestyle modifications, and social function along with research priorities. Descriptive statistics were generated. Linear regression was used to assess the independent effects of obesity and other covariates on social function.ResultsOf 106 respondents, 60 (57%) reported their child had obesity at the time of survey completion. In contrast, only 6 (5.7%) had obesity prior to craniopharyngioma diagnosis. A majority (92%) of those with obesity had tried limiting calories or carbohydrates; 31% and 69% found these helpful, respectively. Thirty-eight percent had tried weight loss medications (stimulants, metformin, GLP1R-agonists, and topiramate) and 48% found at least one helpful. Both stimulant and anti-depressant use were reported more frequently with obesity. An index (T-score) reflecting social function was lower in the cohort than a population reference, 41 (SD 11) vs. 50 (SD 10), p<0.001. In a linear model, both older age and obesity were independently associated with greater social impairment. Ninety-four percent of respondents caring for a child with obesity (and 79% of all respondents) identified “improving treatments and prevention for hypothalamic obesity” as a key research priority.ConclusionsOnly a minority of individuals with hypothalamic obesity had trialed medication, even though many reported that lifestyle modification was inadequate. Furthermore, social function was significantly impaired overall in survivors compared to a reference cohort, and even more so in individuals with obesity. These findings highlight the opportunity to improve social functioning as an additional potential benefit of improved treatments for hypothalamic obesity.
first_indexed 2024-04-13T08:24:21Z
format Article
id doaj.art-309c55f371ea4e828dbd0be4be0d21f8
institution Directory Open Access Journal
issn 1664-2392
language English
last_indexed 2024-04-13T08:24:21Z
publishDate 2022-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj.art-309c55f371ea4e828dbd0be4be0d21f82022-12-22T02:54:31ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922022-05-011310.3389/fendo.2022.876770876770A Survey of Patient-Relevant Outcomes in Pediatric Craniopharyngioma: Focus on Hypothalamic ObesityMeghan Craven0Julia H. Crowley1Lucas Chiang2Cassie Kline3Fatema Malbari4Matthew C. Hocking5Matthew C. Hocking6Shana E. McCormack7Division of Endocrinology and Diabetes, Department of Pediatrics, Children’s Hospital of Philadelphia, Philadelphia, PA, United StatesDivision of Endocrinology and Diabetes, Department of Pediatrics, Children’s Hospital of Philadelphia, Philadelphia, PA, United StatesDivision of Endocrinology and Diabetes, Department of Pediatrics, Children’s Hospital of Philadelphia, Philadelphia, PA, United StatesDivision of Oncology, Department of Pediatrics, Children’s Hospital of Philadelphia, Philadelphia, PA, United StatesDivision of Neurology and Developmental Neurosciences, Department of Pediatrics, Texas Children’s Hospital, Houston, TX, United StatesDivision of Oncology, Department of Pediatrics, Children’s Hospital of Philadelphia, Philadelphia, PA, United StatesDepartment of Child and Adolescent Psychiatry and Behavioral Sciences, Children’s Hospital of Philadelphia, Philadelphia, PA, United StatesDivision of Endocrinology and Diabetes, Department of Pediatrics, Children’s Hospital of Philadelphia, Philadelphia, PA, United StatesContextIndividuals treated for pediatric craniopharyngioma, a rare, grade 1 brain tumor, frequently develop hypothalamic obesity, a complication often recalcitrant to intervention. Although hypothalamic obesity is known to adversely impact quality of life, less is known about how caregivers and patients experience this condition.ObjectiveOur goal was to examine the approaches that families take towards weight management and the impact on social function in individuals with craniopharyngioma and obesity. Individuals with craniopharyngioma without obesity were included as a comparison.Subjects and MethodsAdult caregivers of children <18y with craniopharyngioma completed a web-based survey posted by a patient advocacy organization between February and July 2020. Questions related to the child’s diagnosis, medications, lifestyle modifications, and social function along with research priorities. Descriptive statistics were generated. Linear regression was used to assess the independent effects of obesity and other covariates on social function.ResultsOf 106 respondents, 60 (57%) reported their child had obesity at the time of survey completion. In contrast, only 6 (5.7%) had obesity prior to craniopharyngioma diagnosis. A majority (92%) of those with obesity had tried limiting calories or carbohydrates; 31% and 69% found these helpful, respectively. Thirty-eight percent had tried weight loss medications (stimulants, metformin, GLP1R-agonists, and topiramate) and 48% found at least one helpful. Both stimulant and anti-depressant use were reported more frequently with obesity. An index (T-score) reflecting social function was lower in the cohort than a population reference, 41 (SD 11) vs. 50 (SD 10), p<0.001. In a linear model, both older age and obesity were independently associated with greater social impairment. Ninety-four percent of respondents caring for a child with obesity (and 79% of all respondents) identified “improving treatments and prevention for hypothalamic obesity” as a key research priority.ConclusionsOnly a minority of individuals with hypothalamic obesity had trialed medication, even though many reported that lifestyle modification was inadequate. Furthermore, social function was significantly impaired overall in survivors compared to a reference cohort, and even more so in individuals with obesity. These findings highlight the opportunity to improve social functioning as an additional potential benefit of improved treatments for hypothalamic obesity.https://www.frontiersin.org/articles/10.3389/fendo.2022.876770/fullhypothalamic obesitypediatric craniopharyngiomasocial functionbrain tumorhypopituitarism
spellingShingle Meghan Craven
Julia H. Crowley
Lucas Chiang
Cassie Kline
Fatema Malbari
Matthew C. Hocking
Matthew C. Hocking
Shana E. McCormack
A Survey of Patient-Relevant Outcomes in Pediatric Craniopharyngioma: Focus on Hypothalamic Obesity
Frontiers in Endocrinology
hypothalamic obesity
pediatric craniopharyngioma
social function
brain tumor
hypopituitarism
title A Survey of Patient-Relevant Outcomes in Pediatric Craniopharyngioma: Focus on Hypothalamic Obesity
title_full A Survey of Patient-Relevant Outcomes in Pediatric Craniopharyngioma: Focus on Hypothalamic Obesity
title_fullStr A Survey of Patient-Relevant Outcomes in Pediatric Craniopharyngioma: Focus on Hypothalamic Obesity
title_full_unstemmed A Survey of Patient-Relevant Outcomes in Pediatric Craniopharyngioma: Focus on Hypothalamic Obesity
title_short A Survey of Patient-Relevant Outcomes in Pediatric Craniopharyngioma: Focus on Hypothalamic Obesity
title_sort survey of patient relevant outcomes in pediatric craniopharyngioma focus on hypothalamic obesity
topic hypothalamic obesity
pediatric craniopharyngioma
social function
brain tumor
hypopituitarism
url https://www.frontiersin.org/articles/10.3389/fendo.2022.876770/full
work_keys_str_mv AT meghancraven asurveyofpatientrelevantoutcomesinpediatriccraniopharyngiomafocusonhypothalamicobesity
AT juliahcrowley asurveyofpatientrelevantoutcomesinpediatriccraniopharyngiomafocusonhypothalamicobesity
AT lucaschiang asurveyofpatientrelevantoutcomesinpediatriccraniopharyngiomafocusonhypothalamicobesity
AT cassiekline asurveyofpatientrelevantoutcomesinpediatriccraniopharyngiomafocusonhypothalamicobesity
AT fatemamalbari asurveyofpatientrelevantoutcomesinpediatriccraniopharyngiomafocusonhypothalamicobesity
AT matthewchocking asurveyofpatientrelevantoutcomesinpediatriccraniopharyngiomafocusonhypothalamicobesity
AT matthewchocking asurveyofpatientrelevantoutcomesinpediatriccraniopharyngiomafocusonhypothalamicobesity
AT shanaemccormack asurveyofpatientrelevantoutcomesinpediatriccraniopharyngiomafocusonhypothalamicobesity
AT meghancraven surveyofpatientrelevantoutcomesinpediatriccraniopharyngiomafocusonhypothalamicobesity
AT juliahcrowley surveyofpatientrelevantoutcomesinpediatriccraniopharyngiomafocusonhypothalamicobesity
AT lucaschiang surveyofpatientrelevantoutcomesinpediatriccraniopharyngiomafocusonhypothalamicobesity
AT cassiekline surveyofpatientrelevantoutcomesinpediatriccraniopharyngiomafocusonhypothalamicobesity
AT fatemamalbari surveyofpatientrelevantoutcomesinpediatriccraniopharyngiomafocusonhypothalamicobesity
AT matthewchocking surveyofpatientrelevantoutcomesinpediatriccraniopharyngiomafocusonhypothalamicobesity
AT matthewchocking surveyofpatientrelevantoutcomesinpediatriccraniopharyngiomafocusonhypothalamicobesity
AT shanaemccormack surveyofpatientrelevantoutcomesinpediatriccraniopharyngiomafocusonhypothalamicobesity